SHIGELLA MULTIPLE ANTIGEN PRESENTING IMMUNOGENIC COMPOSITION AND FUSION PROTEINS THEREOF

METHODS OF PRODUCING SHIGA TOXIN B-SUBUNIT (STXB) MONOMERS AND OLIGOMERS, AND USES THEREOF

INTRANASAL POLYSACCHARIDE CONJUGATE NANOMULSION VACCINES AND METHODS OF USING THE SAME

A MAPS VACCINE TARGETING SALMONELLA ENTERICA SEROVARS

METHODS OF USE & COMPOSITIONS OF IBD, IBS, & ANTINEOPLASTICMICROBIAL THERAPEUTICS

Shigella Vaccine

Methods and compositions related to the next generation vaccine

BIOCONJUGATES MADE FROM RECOMBINANT N-GLYCOSYLATED PROTEINS FROM PROCARYOTIC CELLS

INORGANIC POLYATOMIC OXYANIONS FOR PROTECTING AGAINST ANTIGENIC DAMAGE DURING PATHOGEN INACTIVATION FOR VACCINE PRODUCTION

A BROADLY PROTECTIVE PROPHYLACTIC VACCINE AGAINST PSEUDOMONAS AERUGINOSA

PSORALEN-INACTIVATED NEISSERIA GONORRHOEAE VACCINES AND METHODS THEREOF

SHIGELLA MULTI-EPITOPE FUSION ANTIGEN PROTEINS AND METHODS OF USE

VACCINES FOR THE TREATMENT AND PREVENTION OF SEASONAL AND EMERGING INFECTIONS

PROTECTED DISACCHARIDES, THEIR PROCESS OF PREPARATION AND THEIR USE IN THE SYNTHESIS OF ZWITTERIONIC OLIGOSACCHARIDES, AND CONJUGATES THEREOF

HIGH DOSE SHIGELLA VACCINE PREPARATION

Inactivating pathogens and producing highly immunogenic inactivated vaccines using a dual oxidation process

Shigella-Tetravalent (Shigella4V) Bioconjugate

GROUP A STREP IMMUNOGENIC COMPOSITIONS WITH POLYSACCHARIDE-PROTEIN CONJUGATES

NOVEL VACCINE COMPOSITIONS

LIVE ATTENUATED ORAL VACCINE AGAINST SHIGELLOSIS AND TYPHOID FEVER

Inactivating pathogens and producing highly immunogenic inactivated vaccines using a dual oxidation process

METHODS OF PRODUCING SHIGA TOXIN B-SUBUNIT (STxB) MONOMERS AND OLIGOMERS, AND USES THEREOF

Methods of Host Cell Modification

METHOD FOR THE PRODUCTION OF OUTER MEMBRANE VESICLES AND IMMUNOGENIC COMPOSITIONS THEREOF

Optimized cell-free synthesis of invasion plasmid antigen B and related compositions and methods of use

METHODS OF USE & COMPOSITIONS OF IBD, IBS, & ANTINEOPLASTIC MICROBIAL THERAPEUTICS

NON-PSYCHOACTIVE CANNABINOIDS AS ADJUVANTS TO ENHANCE MUCOSAL IMMUNITY

Inorganic polyatomic oxyanions for protecting against antigenic damage during pathogen inactivation for vaccine production

Enhanced -enterotoxigenic multi-valent vaccine

Bioconjugates made from recombinant N-glycosylated proteins from procaryotic cells

Mucosal adjuvants and delivery systems

Immunogenic compositions

Live attenuated oral vaccine against ETEC and typhoid fever

D-glycero-B-D-heptose 1-phosphate (HMP) conjugates and use for targeted immune modulation

Inactivating pathogens and producing highly immunogenic inactivated vaccines using a dual oxidation process

Chemical synthesis method of serotype O51 O-antigen oligosaccharide

Inorganic polyatomic oxyanions for protecting against antigenic damage during pathogen inactivation for vaccine production

Artificial invaplex formulated with deacylated lipopolysaccharide

Alginate chitosan nanoformulation of OmpA—a protein subunit

Combined enteropathogen recombinant construct

Live attenuated oral vaccine against shigellosis and typhoid fever

Immunogenic compositions

Vaccine composition for treating or preventing shigellosis

Modified endotoxic bacteria lipopolysaccharide (variants), combination of modified lipopolysaccharides (variants) and, containing same, a vaccine (variants) and a pharmaceutical composition (variants)

Toxoid preparation and uses thereof

Combined enteropathogen recombinant construct

Methods of host cell modification

Method of treating protozoal gastrointestinal disorders in immunocompromised patients

Vaccine against colibacillosis

TOXOID PREPARATION AND USES THEREOF

Methods and compositions based on Shiga toxin type 2 protein

AN ISOLATED IMMUNOGENIC BACTERIAL ANTIGEN AND ITS USE IN THE PREVENTION AND TREATMENT OF INFECTIONS CAUSED BY GRAM-NEGATIVE BACTERIA

Protein matrix vaccines and related methods of making and administering such vaccines

Formulations

Immunogenic antigens of shigella

Live attenuated Shigella vaccine

Multifunctional oral vaccine based on chromosome recombineering

PURIFICATION OF BACTERIAL VESICLES

Biosynthetic system that produces immunogenic polysaccharides in prokaryotic cells

Vaccine for protection against disease

Live, oral vaccine for protection against serotype 1

Combinations of gene deletions for live attenuated shigella vaccine strains

Bacterial vaccine

Bioconjugates made from recombinant N-glycosylated proteins from procaryotic cells

METHODS FOR CONJUGATION OF OLIGOSACCHARIDES OR POLYSACCHARIDES TO PROTEIN CARRIERS THROUGH OXIME LINKAGES VIA 3-DEOXY-D-MANNO-OCTULSONIC ACID

Vaccine for

-derived vector and methods of using the same

Glycoconjugates and their use as potential vaccines against infection by

Live, oral vaccine for protection against serotype 1

Exopolysaccharide of bacteria, method for producing same, vaccine and phamaceutical composition containing same

GLYCOCONJUGATES AND THEIR USE AS POTENTIAL VACCINES AGAINST INFECTION BY SHIGELLA FLEXNERI

Immunogenic composition

Broadly protective vaccine based on type III secretion apparatus proteins

Vaccine for protection against disease

Live, oral vaccine for protection against serotype 1

Biosynthetic system that produces immunogenic polysaccharides in prokaryotic cells

PURIFICATION OF BACTERIAL VESICLES

Anti-sepsis conjugate vaccine

Ricin ribosome binding protein compositions and methods of use thereof

Vaccine for protection against disease

Live, oral vaccine for protection against serotype 1

Methods and compositions based on shiga toxin type 2 protein

Oral vaccine

Vaccine for shigella

Bioconjugates made from recombinant N-glycosylated proteins from procaryotic cells

Formulation for room temperature stabilization of a live attenuated bacterial vaccine

Anti-sepsis conjugate vaccine

Targeting the histone code as a bacterial strategy for selectively modulating gene expression

Shigella mutants in the functions pertaining to the processes of maturing and recycling peptidoglycans and their uses as immunogens

Vaccine for protection against disease

VACCINES

SHIGELLA IPAD PROTEIN AND ITS USE AS A VACCINE AGAINST SHIGELLA INFECTION

Methods for conjugation of oligosaccharides or polysaccharides to protein carriers through oxime linkages via 3-deoxy-D-manno-octulsonic acid

protein antigens and methods

protein antigens and methods

Bacterial ghost (BG) production process using betapropiolactone (BPL) for final inactivation

Targeting the histone code as a bacterial strategy for selectively modulating gene expression

NON-TOXIC MUTANTS OF PATHOGENIC GRAM-NEGATIVE BACTERIA

Combinations of gene deletions for live attenuated vaccine strains

Artificial invaplex

Live, oral vaccine for protection against serotype 1

Glycoconjugates and their use as potential vaccines against infection by

Hybrid Shiga-like toxin

Protein matrix vaccines and methods of making and administering such vaccines

Conjugation of biomolecules using Diels-Alder cycloaddition

Construction of live attenuated vaccine strains that express CFA/I antigens (CfaB and CfaE) and the B subunit of heat-labile enterotoxin (LTB) from enterotoxigenic

Non-toxic mutants of pathogenic gram-negative bacteria

Targeting the histone code as a bacterial strategy for selectively modulating gene expression

Non-toxic mutants of pathogenic gram-negative bacteria

Method of isolating biologically active fraction containing clinically acceptable native S-lipopolysaccharides obtained from bacteria producing endotoxic lipopolysaccharides

Transformed

Anti-sepsis conjugate vaccine

Plasmid maintenance system for antigen delivery

Plasmid maintenance system for antigen delivery

Plasmid maintenance system for antigen delivery

Vaccine for protection against disease

Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability

Non-toxic mutants of pathogenic gram-negative bacteria

Transformed

Invaplex from gram negative bacteria, method of purification and methods of use

Plasmid maintenance system for antigen delivery